✦ LIBER ✦

Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma

✍ Scribed by Fujimoto, Daichi; Tomii, Keisuke; Otoshi, Takehiro; Kawamura, Takahisa; Tamai, Koji; Takeshita, Junpei; Tanaka, Kosuke; Matsumoto, Takeshi; Monden, Kazuya; Nagata, Kazuma; Otsuka, Kyoko; Nakagawa, Atsushi; Hata, Akito; Tachikawa, Ryo; Otsuka, Kojiro; Hamakawa, Hiroshi; Katakami, Nobuyuki; Takahashi, Yutaka; Imai, Yukihiro

Book ID: 122068814
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 375 KB
Volume: 80
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2013.01.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Good response to pemetrexed in patients

Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations

✍ Wu, Shang-Gin; Yang, Chih-Hsin; Yu, Chong-Jen; Lee, Jih-Hsiang; Hsu, Ya-Chieh; C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Interstitial lung disease in patients wi

Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors

✍ Masahiro Tsuboi; Thierry Le Chevalier 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 111 KB

Frequency of epidermal growth factor rec

Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung

✍ Rahman, Shakibur; Kondo, Nobuyuki; Yoneda, Kazue; Takuwa, Teruhisa; Hashimoto, M 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 177 KB

Serum carcinoembryonic antigen level is

Serum carcinoembryonic antigen level is associated with epidermal growth factor receptor mutations in recurrent lung adenocarcinomas

✍ Fumihiro Shoji; Ichiro Yoshino; Tokujiro Yano; Takuro Kometani; Taro Ohba; Hiden 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract ## BACKGROUND. The presence of epidermal growth factor receptor (EGFR) gene mutations is a good indicator of the clinical efficacy of gefitinib in patients with nonsmall cell lung cancer. It was recently reported that the serum carcinoembryonic antigen (CEA) level could be a predictive

Restoration of tumour suppressor hsa-miR

Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation

✍ William C.S. Cho; Andrew S.C. Chow; Joseph S.K. Au 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 708 KB

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma

✍ Shinichi Toyooka; Toshimi Takano; Takayuki Kosaka; Katsuyuki Hotta; Keitaro Mats 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB